[DPHARMA] QoQ Quarter Result on 30-Sep-2024 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
08-Nov-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Sep-2024 [#3]
Profit Trend
QoQ--%
YoY--%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 208,732 218,324 192,968 167,501 169,235 167,516 200,475 2.71%
PBT 20,520 21,960 20,101 7,034 11,427 16,515 28,292 -19.22%
Tax -4,925 -5,271 -4,824 1,468 -2,457 -3,974 -5,659 -8.82%
NP 15,595 16,689 15,277 8,502 8,970 12,541 22,633 -21.93%
-
NP to SH 15,595 16,689 15,277 8,502 8,970 12,541 22,633 -21.93%
-
Tax Rate 24.00% 24.00% 24.00% -20.87% 21.50% 24.06% 20.00% -
Total Cost 193,137 201,635 177,691 158,999 160,265 154,975 177,842 5.63%
-
Net Worth 693,111 692,598 682,979 682,979 673,359 670,448 666,567 2.63%
Dividend
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Div - 9,619 - 17,314 - 4,788 - -
Div Payout % - 57.64% - 203.66% - 38.19% - -
Equity
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Net Worth 693,111 692,598 682,979 682,979 673,359 670,448 666,567 2.63%
NOSH 962,654 961,942 961,942 961,942 961,942 961,942 952,239 0.72%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 7.47% 7.64% 7.92% 5.08% 5.30% 7.49% 11.29% -
ROE 2.25% 2.41% 2.24% 1.24% 1.33% 1.87% 3.40% -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 21.68 22.70 20.06 17.41 17.59 17.49 21.05 1.97%
EPS 1.62 1.73 1.59 0.88 0.93 1.31 2.38 -22.56%
DPS 0.00 1.00 0.00 1.80 0.00 0.50 0.00 -
NAPS 0.72 0.72 0.71 0.71 0.70 0.70 0.70 1.89%
Adjusted Per Share Value based on latest NOSH - 962,654
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 21.68 22.68 20.05 17.40 17.58 17.40 20.83 2.69%
EPS 1.62 1.73 1.59 0.88 0.93 1.30 2.35 -21.91%
DPS 0.00 1.00 0.00 1.80 0.00 0.50 0.00 -
NAPS 0.72 0.7195 0.7095 0.7095 0.6995 0.6965 0.6924 2.63%
Price Multiplier on Financial Quarter End Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 30/09/24 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 -
Price 1.36 1.26 1.20 1.26 1.20 1.30 1.56 -
P/RPS 6.27 5.55 5.98 7.24 6.82 7.43 7.41 -10.51%
P/EPS 83.95 72.63 75.56 142.56 128.69 99.28 65.63 17.78%
EY 1.19 1.38 1.32 0.70 0.78 1.01 1.52 -15.01%
DY 0.00 0.79 0.00 1.43 0.00 0.38 0.00 -
P/NAPS 1.89 1.75 1.69 1.77 1.71 1.86 2.23 -10.41%
Price Multiplier on Announcement Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 08/11/24 15/08/24 23/05/24 22/02/24 08/11/23 24/08/23 22/05/23 -
Price 1.25 1.17 1.26 1.21 1.22 1.19 1.44 -
P/RPS 5.76 5.16 6.28 6.95 6.93 6.80 6.84 -10.79%
P/EPS 77.16 67.44 79.34 136.90 130.83 90.88 60.59 17.43%
EY 1.30 1.48 1.26 0.73 0.76 1.10 1.65 -14.65%
DY 0.00 0.85 0.00 1.49 0.00 0.42 0.00 -
P/NAPS 1.74 1.62 1.77 1.70 1.74 1.70 2.06 -10.61%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment